Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enbrel in Early Pediatric Complex Regional Pain Syndrome
NCT02031211Withdrawn
- Sponsor
- Stanford University
- Start
- Jun 2014
- Primary completion
- Oct 2016
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Randomised, double-blind trial of etanercept in complex regional pain syndrome (CRPS), sponsored by Stanford University. Primary endpoint: Visual Analog Scale at 8 weeks. Planned start Jun 2014; status: withdrawn.
02
Drugs
etanercept
03
Conditions
complex regional pain syndrome (CRPS)
Beyond the preview
Go deeper on NCT02031211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02031211.